July 25, 2021
3 min watch
Save
VIDEO: Mitro discusses potential avenues for new drug therapies
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
LAS VEGAS — At the Eyecelerator@ASCRS meeting, Tom Mitro, president and chief operating officer at Aerie, discusses candidates that may help Aerie gain a foothold in other ophthalmic disease states, including a pan-VEGF inhibitor.
Published by:
Sources/Disclosures
Collapse
Source:
Tom Mitro
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.